A Randomized, Double-Blind, Placebo-Controlled Study of Odanacatib (MK-822) in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 24-Month Results

被引：0
|
作者：
McClung, M. [1 ]
Bone, H. [2 ]
Cosman, F. [3 ]
Roux, C. [4 ]
Verbruggen, N. [5 ]
Hustad, C. [6 ]
DaSilva, C. [6 ]
Santora, A. [6 ]
Ince, A. [6 ]
机构：
[1] Oregon Osteoporosis Ctr, Portland, OR USA
[2] Michigan Bone & Mineral Ctr, Detroit, MI USA
[3] Helen Hayes Hosp, W Haverstraw, NY USA
[4] Univ Paris, Cochin Hosp, F-75252 Paris, France
[5] Merck Res Labs, Brussels, Belgium
[6] Merck Res Labs, Rahway, NJ USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [1] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ODANACATIB (MK-822) IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: RESULTS AT 24 MONTHS
    Roux, C.
    Santora, A.
    Eisman, J.
    Bone, H.
    McClung, M.
    Recker, R.
    Verbruggen, N.
    Hustad, C.
    Dasilva, C.
    Kimmel, D.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 22 - 22
  • [2] Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density
    Eisman, J. A.
    Recker, R. R.
    McClung, M.
    Bone, H.
    Roux, C.
    Verbruggen, N.
    Hustad, C. M.
    DaSilva, C.
    Santora, A.
    Ince, A.
    BONE, 2009, 44 : S103 - S104
  • [3] TWO YEAR RESULTS IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ODANACATIB (MK-822) IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Eisman, J. A.
    Recker, R. R.
    Kimmel, D.
    McClung, M.
    Bone, H.
    Roux, C.
    Verbruggen, N.
    Hustad, C.
    DaSilva, C.
    Santora, A.
    Ince, A.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (01) : 167 - 168
  • [4] A randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in the treatment of postmenopausal women with low bmd: 18-month results
    McClung, M.
    Bone, H.
    Verbruggen, N.
    Rybak-Feiglin, A.
    daSilva, C.
    Santora, A.
    Ince, A.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S53 - S53
  • [5] Odanacatib treatment in postmenopausal women with low bone mineral density: 24-month results
    McClung, M.
    Eisman, J. A.
    Bone, H. G.
    Roux, C.
    Recker, R. R.
    Verbruggen, N.
    Hustad, C. M.
    daSilva, C.
    Kimmel, D.
    Santora, A.
    Ince, A.
    BONE, 2009, 44 (02) : S438 - S438
  • [6] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY OF CLASSIC YIN AND YANG TONIC FORMULA FOR POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Tang, D.
    Li, C.
    Xuejun, C.
    Yang, F.
    Shi, Q.
    Wang, Y.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S609 - S609
  • [7] A randomized, double-blind, placebo-controlled study of a cathepsin-K inhibitor in the treatment of postmenopausal women with Low BMD: 18 month results
    Ince, Avery
    McClung, Michael
    Bone, Henry
    Verbruggen, Nadia
    Rybak-Feiglin, Andrea
    dasilva, Carolyn
    Santora, Arthur
    BONE, 2008, 42 : S74 - S74
  • [8] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate on Bone Mineral Density and Bone Remodelling in Perimenopausal Women With Low Bone Mineral Density
    Khan, Aliya
    Dubois, Sacha
    Khan, Amina A.
    Rahman, Zohair
    Khan, O. Ahmed
    Syed, Hamid T.
    Derzko, Christine
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2014, 36 (11) : 976 - 982
  • [9] Effects of bendroflumethiazide on bone mineral density; results from the BONATHIAD randomized double-blind placebo-controlled cohort study
    Emmanuel, Thomas
    Kruse, Christian
    Leere, Julius Simoni
    Poulsen, Trine Holmgaard
    Vestergaard, Peter
    BONE REPORTS, 2020, 13
  • [10] A double-blind, placebo-controlled, phase III Study of bazedoxifene/conjugated estrogens in postmenopausal women: Effects on bone mineral density
    Lindsay, R.
    Ronkin, S.
    Constantine, G.
    Olivier, S.
    Pickar, J.
    BONE, 2009, 44 : S37 - S37
12345